• 1887 Citations
  • 19 h-Index
20042020
If you made any changes in Pure these will be visible here soon.

Research Output 2004 2020

Filter
Review article
2019

Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasms

Forsyth, C. J., Chan, W. H., Grigg, A. P., Cook, N. C., Lane, S. W., Burbury, K. L., Perkins, A. C. & Ross, D., 1 Jan 2019, In : Internal Medicine Journal. 49, 8, p. 948-954 7 p.

Research output: Contribution to journalReview article

2018
7 Citations (Scopus)

Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factors

Ross, D., Arthur, C., Burbury, K., Ko, B. S., Mills, A. K., Shortt, J. & Kostner, K., 1 Feb 2018, In : Internal Medicine Journal. 48, p. 5-13 9 p.

Research output: Contribution to journalReview article

2017
3 Citations (Scopus)

Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome

Shanmuganathan, N., Hiwase, D. K. & Ross, D. M., 2 Dec 2017, In : Leukemia and Lymphoma. 58, 12, p. 2799-2810 12 p.

Research output: Contribution to journalReview article

2016
152 Citations (Scopus)

Moving treatment-free remission into mainstream clinical practice in CML

Hughes, T. P. & Ross, D. M., 7 Jul 2016, In : Blood. 128, 1, p. 17-23 7 p.

Research output: Contribution to journalReview article

2015
14 Citations (Scopus)

Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia

Hotinski, A. K., Lewis, I. D. & Ross, D., 1 Jan 2015, In : Expert Opinion on Pharmacotherapy. 16, 9, p. 1395-1402 8 p.

Research output: Contribution to journalReview article

2013
23 Citations (Scopus)

Practical management of patients with myelofibrosis receiving ruxolitinib

Harrison, C., Mesa, R., Ross, D., Mead, A., Keohane, C., Gotlib, J. & Verstovsek, S., 24 Oct 2013, In : Expert Review of Hematology. 6, 5, p. 511-523 13 p.

Research output: Contribution to journalReview article

2011
26 Citations (Scopus)

Do we have to kill the last CML cell

Ross, D. M., Hughes, T. P. & Melo, J. V., 1 Jan 2011, In : Leukemia. 25, 2, p. 193-200 8 p.

Research output: Contribution to journalReview article

2004
7 Citations (Scopus)

Assessment of early paraprotein response to vincristine-doxorubicin- dexamethasone chemotherapy may help guide therapy in multiple myeloma

Ross, D., To, L. B. & Horvath, N., 1 Sep 2004, In : Internal Medicine Journal. 34, 9-10, p. 576-578 3 p.

Research output: Contribution to journalReview article